US EditionRemidio and RetinaRisk collaborate on risk-based eye screening using AI
Summary by MediaBrief
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Remidio and RetinaRisk collaborate on risk-based eye screening using AI
Remidio Innovative Solutions, a provider of AI-powered ophthalmic diagnostics, has announced a strategic partnership with RetinaRisk, a health tech company from Iceland, to enhance risk-based diabetic retinopathy (DR) screening in India and Iceland. This partnership brings together two innovations: Remidio’s Medios DR AI for automated DR detection and RetinaRisk’s personalized risk triaging algorithm for progression […] The post Remidio and Reti…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
